AHR and pulmonary fibrosis: This work sheds mechanistic light on how cellular crosstalk between nonimmune cells, e.g., fibroblasts, and immune cells like DCs occurs during complex pathologies and brings to light the possibility of utilizing AHR modulation as an immunotherapy for post-BMT pulmonary pathologies and pulmonary fibrosis.